Spearhead Capital Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,232
| Closed | -$252K | – | 148 |
|
|
2022
Q2 | $252K | Sell |
4,232
-58
| -1% | -$3.45K | 0.04% | 140 |
|
|
2022
Q1 | $312K | Buy |
4,290
+381
| +10% | +$27.7K | 0.04% | 129 |
|
|
2021
Q4 | $329K | Buy |
3,909
+388
| +11% | +$32.7K | 0.04% | 140 |
|
|
2021
Q3 | $318K | Buy |
3,521
+203
| +6% | +$18.3K | 0.04% | 146 |
|
|
2021
Q2 | $316K | Buy |
3,318
+550
| +20% | +$52.4K | 0.04% | 174 |
|
|
2021
Q1 | $315K | Buy |
+2,768
| New | +$315K | 0.05% | 157 |
|